Clinical and Pathologic Studies in Neuroendocrine Tumors

This study has been terminated.

Sponsored by:	Stanford University
Information provided by:	Stanford University
ClinicalTrials.gov Identifier:	NCT00657332

Purpose

This research involves the study of neuroendocrine tumors in order to better understand how the disease grows and spreads. This study requires will use tissue collected from from biopsies performed during your regular medical care (i.e. tissue leftover after your diagnosis has been made) and/or blood and urine samples. This study may lead to the development of special materials that could be used, in the future, to treat neuroendocrine tumors or to follow the response of neuroendocrine tumors to treatment

Condition	Intervention
Neuroendocrine Tumors Carcinoid Tumor	Procedure: blood sample draw Procedure: urine sample

MedlinePlus related topics: Cancer Carcinoid Tumors Urine and Urination

U.S. FDA Resources

Study Type:	Observational
Study Design:	Prospective
Official Title:	Clinical and Pathologic Studies in Neuroendocrine Tumors

Further study details as provided by Stanford University:

Estimated Enrollment:

200

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:- Patients are eligible if they have a histologically proven neuroendocrine tumor and are 18 years of age or older

- Ability to understand and the willingness to sign a written informed consent document.
 Exclusion Criteria:None

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00657332

Locations

United States, California
Stanford University School of Medicine
Stanford, California, United States, 94305

Sponsors and Collaborators

Stanford University

Investigators

Principal Investigator:

George Albert Fisher M.D. Ph.D.

Stanford University

More Information

Study ID Numbers:	SU-12102007-931, 98132, END0005
Study First Received:	April 9, 2008
Last Updated:	October 3, 2008
ClinicalTrials.gov Identifier:	NCT00657332
Health Authority:	USA:IRB

Study placed in the following topic categories:

Carcinoid tumor
Neuroectodermal Tumors
Neoplasms, Germ Cell and Embryonal
Neuroepithelioma
Carcinoid Tumor

Adenocarcinoma
Neoplasms, Glandular and Epithelial
Carcinoma
Neuroendocrine Tumors

Additional relevant MeSH terms:

Neoplasms
Neoplasms by Histologic Type
Neoplasms, Nerve Tissue

ClinicalTrials.gov processed this record on January 16, 2009